The Impact of COVID-19 is included in Heart Failure Drug Market Report. Buy it today to get an advantage.
Request the impact of COVID-19 on your product or industry
Heart Failure Drug Trends and Forecast
The future of the global heart failure drug market looks promising with opportunities in the hospital pharmacy, retail pharmacy, and online pharmacy markets. The global heart failure drug market is expected to reach an estimated $17.1 billion by 2030 with a CAGR of 12.5% from 2024 to 2030. The major drivers for this market are increasing cardiovascular diseases, rising demand for r&d activities related to cardiovascular diseases, and growing aging population.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Heart Failure Drug by Segment
The study includes a forecast for the global heart failure drug by drug type, application, end use, distribution channel, and region.
Heart Failure Drug Market by Drug Type [Shipment Analysis by Value from 2018 to 2030]:
• Ace Inhibitors
• Angiotensin Receptor Blockers
• Beta Blockers
• Diuretics
• Others
Heart Failure Drug Market by Application [Shipment Analysis by Value from 2018 to 2030]:
• Injection
• Capsule
• Tablets
Heart Failure Drug Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
• Hospitals
• Specialty Centres
• Others
Heart Failure Drug Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
Heart Failure Drug Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Heart Failure Drug Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies heart failure drug companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the heart failure drug companies profiled in this report include-
• Bayer
• Novartis
• Amgen
• Merck
• Astrazeneca
• Bristol-Myers Squibb
• Boehringer Ingelheim International
• Pfizer
• Johnson & Johnson Services
• Otsuka Pharmaceutical
Heart Failure Drug Market Insights
Lucintel forecasts that ace inhibitors will remain the largest segment because it helps in preventing the formation of angiotensin that results in blood vessels to constrict, and beta blockers block the action of certain chemicals.
Within this market, retail pharmacies will remain the largest segment due to ease at managing prescriber medications, especially for heart diseases in the homecare setting where long-term support is needed.
North America is expected to witness highest growth over the forecast period due to increasing prevelance of heart failure cases and geriatic population in the region.
Features of the Global Heart Failure Drug Market
Market Size Estimates: Heart failure drug market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Heart failure drug market size by various segments, such as by drug type, application, end use, distribution channel, and region in terms of ($B).
Regional Analysis: Heart failure drug market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different drug types, applications, end uses, distribution channels, and regions for the heart failure drug market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the heart failure drug market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q.1 What is the heart failure drug market size?
Answer: The global heart failure drug market is expected to reach an estimated $17.1 billion by 2030.
Q.2 What is the growth forecast for heart failure drug market?
Answer: The global heart failure drug market is expected to grow with a CAGR of 12.5% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the heart failure drug market?
Answer: The major drivers for this market are increasing cardiovascular diseases, rising demand for r&d activities related to cardiovascular diseases and growing aging population.
Q4. What are the major segments for heart failure drug market?
Answer: The future of the heart failure drug market looks promising with opportunities in the hospital pharmacy, retail pharmacy, and online pharmacy markets.
Q5. Who are the key heart failure drug market companies?
Answer: Some of the key heart failure drug companies are as follows:
• Bayer
• Novartis
• Amgen
• Merck
• Astrazeneca
• Bristol-Myers Squibb
• Boehringer Ingelheim International
• Pfizer
• Johnson & Johnson Services
• Otsuka Pharmaceutical
Q6. Which heart failure drug market segment will be the largest in future?
Answer: Lucintel forecasts that ace inhibitors will remain the largest segment because it helps in preventing the formation of angiotensin that results in blood vessels to constrict, and beta blockers block the action of certain chemicals.
Q7. In heart failure drug market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness highest growth over the forecast period due to increasing prevelance of heart failure cases and geriatic population in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the heart failure drug market by drug type (ace inhibitors, angiotensin receptor blockers, beta blockers, diuretics, and others), application (injection, capsule, and tablets), end use (hospitals, specialty centres, and others), distribution channel (hospital pharmacies, retail pharmacies, and online pharmacies), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Heart Failure Drug Market, Heart Failure Drug Market Size, Heart Failure Drug Market Growth, Heart Failure Drug Market Analysis, Heart Failure Drug Market Report, Heart Failure Drug Market Share, Heart Failure Drug Market Trends, Heart Failure Drug Market Forecast, Heart Failure Drug Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.
Table of Contents
1. Executive Summary
2. Global Heart Failure Drug Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Heart Failure Drug Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Heart Failure Drug Market by Drug Type
3.3.1: ACE Inhibitors
3.3.2: Angiotensin Receptor Blockers
3.3.3: Beta Blockers
3.3.4: Diuretics
3.3.5: Others
3.4: Global Heart Failure Drug Market by Application
3.4.1: Injection
3.4.2: Capsule
3.4.3: Tablets
3.5: Global Heart Failure Drug Market by End Use
3.5.1: Hospitals
3.5.2: Specialty Centres
3.5.3: Others
3.6: Global Heart Failure Drug Market by Distribution Channel
3.6.1: Hospital Pharmacies
3.6.2: Retail Pharmacies
3.6.3: Online Pharmacies
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Heart Failure Drug Market by Region
4.2: North American Heart Failure Drug Market
4.2.2: North American Heart Failure Drug Market by Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies
4.3: European Heart Failure Drug Market
4.3.1: European Heart Failure Drug Market by Drug Type: ACE Inhibitors, Angiotensin Receptor Blockers, Beta Blockers, Diuretics, and Others
4.3.2: European Heart Failure Drug Market by Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies
4.4: APAC Heart Failure Drug Market
4.4.1: APAC Heart Failure Drug Market by Drug Type: ACE Inhibitors, Angiotensin Receptor Blockers, Beta Blockers, Diuretics, and Others
4.4.2: APAC Heart Failure Drug Market by Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies
4.5: ROW Heart Failure Drug Market
4.5.1: ROW Heart Failure Drug Market by Drug Type: ACE Inhibitors, Angiotensin Receptor Blockers, Beta Blockers, Diuretics, and Others
4.5.2: ROW Heart Failure Drug Market by Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Heart Failure Drug Market by Drug Type
6.1.2: Growth Opportunities for the Global Heart Failure Drug Market by Application
6.1.3: Growth Opportunities for the Global Heart Failure Drug Market by End Use
6.1.4: Growth Opportunities for the Global Heart Failure Drug Market by Distribution Channel
6.1.5: Growth Opportunities for the Global Heart Failure Drug Market by Region
6.2: Emerging Trends in the Global Heart Failure Drug Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Heart Failure Drug Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Heart Failure Drug Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: Bayer
7.2: Novartis
7.3: Amgen
7.4: Merck
7.5: AstraZeneca
7.6: Bristol-Myers Squibb
7.7: Boehringer Ingelheim International
7.8: Pfizer
7.9: Johnson & Johnson Services
7.10: Otsuka Pharmaceutical
.
Buy full report or by chapter as follows
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Please sign in below to get report brochure - Heart Failure Drug Market Report.